Harvard-Emory ECG Database v4.0: Large Collection of 12-Lead Electrocardiography Recordings
By
teleforce
Kettled twice. Extra chewy, extra trustworthy.
Summary
The Harvard-Emory ECG Database v4.0 is a comprehensive collection of 12-lead electrocardiography (ECG) recordings developed by researchers from Harvard and Emory universities. This scientific database serves as a valuable resource for medical research, particularly in cardiology and biomedical signal processing. The database includes proper citation information and is hosted on the Brain Data Science Platform with a DOI for academic reference.
Key quotes
· 3 pulledKoscova, Z., Moura Junior, V., Reyna, M., Hong, S., Gupta, A., Ghanta, M., Sameni, R., Aguirre, A., Li, Q., Zafar, S., Clifford, G., & Westover, M. B. (2025). Harvard-Emory ECG Database (version 4.0). Brain Data Science Platform.
The Harvard ECG database (HEEDB) is a large collection of 12-lead electrocardiography (ECG) recordings.
Harvard-Emory ECG Database (version 4.0). Brain Data Science Platform (2025), https://doi.org/10.60508/rv6h-7d10.
You might also wanna read
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·2h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·15h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·18h ago